KEYNOTE-426: no QoL differences pembrolizumab + axitinib versus sunitinib

Presented By

Prof. Jens Bedke, University of Tübingen, Germany

Trial

Phase 3, KEYNOTE-426

Conference

EAU 2020

20 August, 2020 10:41

Debate: upfront cytoreductive nephrectomy or not?

Presented By

Prof. Axel Bex & Prof. Antonio Finelli

Trial

Phase 3, CARMENA; SURTIME

Conference

EAU 2020

20 August, 2020 09:29

Presented By

Dr Alessandro Larcher, Ospedale San Raffaele, Italy

Trial

IRON

Conference

EAU 2020

20 August, 2020 09:22